Chronic Lymphocytic Leukemia - Alberta Health Services
Chronic Lymphocytic Leukemia - Alberta Health Services
Chronic Lymphocytic Leukemia - Alberta Health Services
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
CLINICAL PRACTICE GUIDELINE LYHE-007<br />
Version 2<br />
<strong>Leukemia</strong> updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008 Jun 15;111(12):5446-<br />
5456.<br />
(4) Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, Henriques AF, et al. Increased frequency (12%) of<br />
circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow<br />
cytometry approach. Blood 2009 Jul 2;114(1):33-37.<br />
(5) Rawstron AC, Bennett FL, O'Connor SJ, Kwok M, Fenton JA, Plummer M, et al. Monoclonal B-cell lymphocytosis<br />
and chronic lymphocytic leukemia. N Engl J Med 2008 Aug 7;359(6):575-583.<br />
(6) Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic<br />
leukemia. Blood 1975 Aug;46(2):219-234.<br />
(7) Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. A new prognostic classification of<br />
chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981 Jul 1;48(1):198-206.<br />
(8) Rai KR. A critical analysis of staging in CLL. In: Gale RP, Rai KR, editors. <strong>Chronic</strong> lymphocytic leukemia: recent<br />
progress and future directions New York: Liss; 1987. p. 253.<br />
(9) Moreno C, Montserrat E. New prognostic markers in chronic lymphocytic leukemia. Blood Rev 2008 Jul;22(4):211-<br />
219.<br />
(10) Tsimberidou AM, Keating MJ. Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia:<br />
need for new treatment options. Leuk Lymphoma 2010 Jul;51(7):1188-1199.<br />
(11) Dreger P, Corradini P, Kimby E, Michallet M, Milligan D, Schetelig J, et al. Indications for allogeneic stem cell<br />
transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. <strong>Leukemia</strong> 2007 Jan;21(1):12-17.<br />
(12) Dal-Bo M, Bertoni F, Forconi F, Zucchetto A, Bomben R, Marasca R, et al. Intrinsic and extrinsic factors<br />
influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic<br />
relevance. J Transl Med 2009 Aug 28;7:76.<br />
(13) Foa R, Ciolli S, Di Raimondo F, Del Poeta G, Lauria F, Forconi F, et al. Rituximab Plus Chlorambucil As Initial<br />
Treatment for Elderly Patients with <strong>Chronic</strong> <strong>Lymphocytic</strong> <strong>Leukemia</strong> (CLL): Effect of Pre-Treatment Biological<br />
Characteristics and Gene Expression Patterns on Response to Treatment. Blood (ASH Annual Meeting Abstracts)<br />
2011 2011;118(21):Abstract 294.<br />
(14) Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of<br />
the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982 Dec;5(6):649-655.<br />
(15) Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968 May;16(5):622-626.<br />
(16) Hallek M, Fingerle-Rowson G, Fink A, Busch R, Mayer J, Hensel M, et al. First-line treatment with fludarabine<br />
(F), cyclophosphamide (C), and rituximab (R) (FCR) improves overall survival (OS) in previously untreated patients<br />
(pts) with advanced chronic lymphocytic leukemia (CLL): Results of a randomized phase III trial on behalf of an<br />
international group of investigators and the German CLL Study Group. Blood (ASH Annual Meeting Abstracts) 2009<br />
Nov;114(22):Abstract 535.<br />
(17) Blum KA, Young D, Broering S, Lucas MS, Fischer B, Lin TS, et al. Computed tomography scans do not improve<br />
the predictive power of 1996 national cancer institute sponsored working group chronic lymphocytic leukemia<br />
response criteria. J Clin Oncol 2007 Dec 10;25(35):5624-5629.<br />
Page 16 of 23
Change language